National Cancer Institute Director Ned Sharpless has reportedly been tapped to serve as the Food and Drug Administration’s interim chief, according to a FirstWord Pharma report.
Sharpless will head the agency after FDA Commissioner Scott Gottlieb’s resignation goes into effect next month.
“Sharpless’ deep scientific background and expertise will make him a strong leader for FDA,” Health and Human Services Secretary Alex Azar said. ” … There will be no let-up in the agency’s focus, from ongoing efforts on drug approvals and combating the opioid crisis.”
According to the report, the search for a permanent replacement to Gottlieb is under way.
To read more on FirstWord Pharma, click here.